Posted on 12/23/16
Oncobiologics Issues $8.35 Million of Senior Secured Notes
CRANBURY, N.J., Dec. 23, 2016 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex monoclonal antibody (mAb) . . .
Posted on 12/21/16
Pfizer Case Study: Building Wealth With A Loser Stock
On 09/07/2001, I bought an initial block of 100 shares of Pfizer (NYSE:PFE), a large pharmaceutical company. It was one of the first individual stocks I . . .
Posted on 12/21/16
Henry Schein Named 'Best Animal Healthcare Product Provider 2016' By Global Health & Pharma
Henry Schein, Inc. (Nasdaq: HSIC) today announced that it has been named "Best Animal Healthcare Product Provider 2016" by Global Health & Pharma (GHP) Magazine, a . . .
Posted on 12/21/16
22nd Century Group Announces Major Scientific Collaboration with University of Virginia
CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company has . . .
Posted on 12/21/16
CR Magazine Ladder Award Recognizes Cigna for Progress in Corporate Responsibility
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna (NYSE: CI), a global health service company, was named to the CR Magazine Ladder Award list as one of 25 companies that made . . .
Posted on 12/20/16
John Bertagnolli Jr., DO, Joins Samaritan Healthcare & Hospice as a Hospice Physician
John Bertagnolli Jr., DO, of Mount Laurel has joined Samaritan Healthcare & Hospice as a hospice physician. He is the
Posted on 12/20/16
Better Buy: Celgene Corporation vs. Johnson & Johnson
Celgene (NASDAQ:CELG) stepped onto Johnson & Johnson's (NYSE:JNJ) turf in 2014 with its launch of Otezla. The drug competes head-to-head with J&J's Stelara in the psoriasis . . .
Posted on 12/20/16
Kindred Healthcare and Atlantic Health System Announce Plans for Inpatient Rehabilitation Hospital
LOUISVILLE, Ky. & MORRISTOWN, N.J.--(BUSINESS WIRE)--Kindred Healthcare, Inc. (NYSE:KND) and Atlantic Health System today announced the signing of a definitive agreement to create a joint venture to . . .
Posted on 12/19/16
The 12 Greatest Medical Breakthroughs of 2016
IMAGE SOURCE: GETTY IMAGES.With less than two weeks to go before we turn the page on 2016, we can look back on another largely successful year . . .
Posted on 12/19/16
The Most Expensive Drugs of 2016
Prescription drug prices have gotten out of control for many Americans and many insurers. Some drugs cost as much as premium sports cars. Here are the . . .
Posted on 12/19/16
3 Low-Volatility Biotech Stocks to Buy
Are you hesitant to buy biotech stocks because of their volatility? If so, it's understandable. Many biotech stocks are very volatile, with frequent big swings up . . .
Posted on 12/19/16
Soligenix Closes Public Offering
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 12/15/16
Better Buy: Pfizer Inc. vs. Merck
This year is turning out quite differently for two of the biggest pharmaceutical companies. Pfizer's (NYSE:PFE) stock is barely above where it started at the beginning . . .
Posted on 12/14/16
Pfizer (PFE) Management Presents at Guggenheim 4th Annual Boston Healthcare Conference (Transcript)
Pfizer Inc. (NYSE:PFE)Guggenheim 4th Annual Boston Healthcare ConferenceDecember 13, 2016 12:00 P.M. ETExecutivesIan C. Read - Chairman and CEOAnalystsUnidentified Analyst - GuggenheimUnidentified AnalystGreetings everyone, I hope . . .
Posted on 12/14/16
Pfizer Just Channeled Its Inner Martin Shkreli (and Paid for It)
IMAGE SOURCE: GETTY IMAGES.This is a point that probably doesn't need to be stated, but prescription drug prices are generally expensive -- and they're seemingly growing . . .
Posted on 12/14/16
Is the Worst Yet to Come for Alexion Pharmaceuticals?
It's usually not a good sign when a company's CEO suddenly departs. It's definitely not a good sign when both the CEO and CFO leave at . . .
Posted on 12/14/16
3 Top Biotech Stocks to Buy on Sale
Despite the turmoil caused by the U.S. presidential election this year, biotech stocks still sport some of the richest valuations in the market. Even so, there . . .
Posted on 12/13/16
Soligenix Prices $5,277,000 Public Offering and Completes Listing on Nasdaq
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 12/13/16
Here's Why Trump's Pledge to Lower Drug Prices Is All Bark and No Bite
IMAGE SOURCE: DISNEY-ABC TELEVISION GROUP VIA FLICKR.In less than six weeks, President-elect Donald Trump will be inaugurated and become the 45th president of the United States. . . .
Posted on 12/13/16
Purdue Pharma and Exicure Announce Strategic Research Collaboration Agreement
STAMFORD, Conn. & SKOKIE, Ill.--(BUSINESS WIRE)--Purdue Pharma L.P. and Exicure, Inc. today announced a strategic research collaboration, option and license agreement to discover and develop a . . .
Posted on 12/12/16
Celldex Therapeutics, Inc.'s Biggest Win in 2016
Celldex Therapeutics (NASDAQ:CLDX) saw its stock take a huge nosedive in 2016. That's what happens when your lead product flops in a late-stage clinical study. Did . . .
Posted on 12/12/16
Can Trump Solve Pfizer's $80 Billion Problem?
Among publicly traded U.S.-based companies, pharma giant Pfizer (NYSE:PFE) has outshined nearly all of its peers in terms of stockpiling cash overseas. Specifically, the drugmaker divulged . . .
Posted on 12/12/16
Better Buy: Amgen Inc. vs. Biogen
Two of the biggest biotechs in the world haven't exactly had a great 2016. Shares of Amgen(NASDAQ:AMGN) and Biogen (NASDAQ:BIIB) are both down year to date. . . .
Posted on 12/9/16
The 3 Best Biotech Stocks for 2017
Trying to pick the best biotech stocks for 2017 -- defined as those with the best returns -- is a bit of a crapshoot. The biotech . . .
Posted on 12/9/16
Pfizer (PFE) Management Presents at Citi Global Healthcare Conference (Transcript)
Call Start: 14:10Call End: 14:48Pfizer Inc. (NYSE:PFE)Citi Global Healthcare Conference CallDecember 8, 2016 14:10 ETExecutivesMikael Dolsten - President, R&DAnalystsAndrew Baum - CitiAndrew BaumAll right, I have . . .
New York
